These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 36988814)

  • 1. Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
    de Oliveira LM; da Silva Dal Pizzol T
    J Med Toxicol; 2023 Jul; 19(3):307-308. PubMed ID: 36988814
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
    Sindelar M; McCabe D; Carroll E
    J Med Toxicol; 2023 Jul; 19(3):309. PubMed ID: 36988815
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.
    Sindelar M; McCabe D; Carroll E
    J Med Toxicol; 2023 Jan; 19(1):45-48. PubMed ID: 36536192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.
    Marsh J; Logan AT; Bilgili EP; Bowman LJ; Webb AR
    Am J Health Syst Pharm; 2024 Jun; 81(13):e345-e352. PubMed ID: 38347740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).
    Lemaitre F; Grégoire M; Monchaud C; Bouchet S; Saint-Salvi B; Polard E; ; ; ; ; ;
    Therapie; 2022; 77(5):509-521. PubMed ID: 35618549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.
    Young C; Papiro T; Greenberg JH
    Pediatr Nephrol; 2023 Apr; 38(4):1387-1388. PubMed ID: 35982345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.
    Schneider J; Wobser R; Kühn W; Wagner D; Tanriver Y; Walz G
    BMC Nephrol; 2023 Apr; 24(1):99. PubMed ID: 37061677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.
    Dewey KW; Yen B; Lazo J; Seijo L; Jariwala R; Shah RJ; Quan D; Carpenter B; Paul Singer J; Breen K; Hays S; Florez R
    Transplantation; 2023 May; 107(5):1200-1205. PubMed ID: 36525555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nirmatrelvir Plus Ritonavir: First Approval.
    Lamb YN
    Drugs; 2022 Apr; 82(5):585-591. PubMed ID: 35305258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient.
    Meaney CJ; O'Connor M; McGowan M; Hamid M; Su W
    J Clin Pharm Ther; 2019 Aug; 44(4):640-643. PubMed ID: 30830975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus toxicity due to enzyme inhibition from ritonavir.
    Snee I; Drobina J; Mazer-Amirshahi M
    Am J Emerg Med; 2023 Jul; 69():218.e5-218.e7. PubMed ID: 37173153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis.
    Tsuzawa A; Katada Y; Umemura K; Sugimoto M; Nishikawa A; Sato YK; Yoshida Y; Kitada N; Yonezawa A; Nakajima D; Date H; Terada T
    J Pharm Health Care Sci; 2023 Apr; 9(1):12. PubMed ID: 37004119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient.
    Shah A; Nasrullah A; Butt MA; Young M
    Eur J Case Rep Intern Med; 2022; 9(9):003528. PubMed ID: 36299835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for Reversal.
    Rose DT; Gandhi SM; Bedard RA; Mondy KE; Chu AL; Gamble KC; Gee AT; Kundra MA; Williams AL; Lee BK
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac238. PubMed ID: 35854994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
    Hung YP; Lee JC; Chiu CW; Lee CC; Tsai PJ; Hsu IL; Ko WC
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Experience of Optimization of Tacrolimus Therapeutic Drug Monitoring in a Patient Cotreated With Nirmatrelvir/Ritonavir: How Microsampling Approach Changes Everything.
    Golbin L; Tron C; Franck B; Vigneau C; Verdier MC; Lemaitre F
    Transplantation; 2023 Feb; 107(2):e68-e69. PubMed ID: 36696522
    [No Abstract]   [Full Text] [Related]  

  • 17. Case Report: Nirmatrelvir/Ritonavir and Tacrolimus in a Kidney Transplant Recipient With COVID-19.
    Lindauer KE; Hamel AG
    Am Fam Physician; 2022 Jun; 105(6):569-570. PubMed ID: 35704835
    [No Abstract]   [Full Text] [Related]  

  • 18. A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case.
    Guyon J; Novion M; Fulda V; Ducint D; Molimard M; Couzi L; Kaminski H; Salvo F; Bouchet S
    J Am Soc Mass Spectrom; 2022 Oct; 33(10):1975-1981. PubMed ID: 36084269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.
    Salerno DM; Jennings DL; Lange NW; Kovac DB; Shertel T; Chen JK; Hedvat J; Scheffert J; Brown RS; Pereira MR
    Am J Transplant; 2022 Aug; 22(8):2083-2088. PubMed ID: 35278260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression.
    Mecadon K; Arvanitis P; Farmakiotis D; Rogers R
    Clin Transplant; 2022 Aug; 36(8):e14752. PubMed ID: 35713302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.